MENU
SGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Seagen (SGEN) Ownership - Who owns Seagen?

Seagen (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
21823 - 30th Drive South East
Phone
+1 425 527-4000
Employees
3256
Web
https://www.seagen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.45B
P/E Ratio
52.91
Total Cash
1.24B
Projected Growth
41.72
Total Debt
113.49M
Revenue
2.3B
Risk (Beta)
0.01
Dividend Yield
N/A
Total Cash/Share
6.56
Total Debt/Equity
N/A
Revenue/Share
12.29 USD as % of share price

Fundamentals

SGEN
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
21823 - 30th Drive South East
Phone
+1 425 527-4000
Employees
3256
Web
https://www.seagen.com